Patents
Patents for C07C 233 - Carboxylic acid amides (28,881)
04/2001
04/03/2001US6211211 Anxiolytic, anticonvulsant and antiepileptic agent
03/2001
03/29/2001WO2001021584A1 Tyrosine derivatives
03/29/2001WO2001021577A2 Melanin concentrating hormone antagonist
03/29/2001WO2001021576A1 Aromatic diamide derivatives or salts thereof, agricultural/horticultural chemicals and method of using the same
03/29/2001WO2001021559A1 Method for hydrogenating organic compounds containing at least one c-c double bond
03/29/2001WO2001021160A2 Carboxymide and aniline derivatives as selective inhibitors of pathogens
03/29/2001WO2000059875A3 Novel inhibitors of formation of advanced glycation endproducts (age's)
03/29/2001CA2386474A1 Melanin concentrating hormone antagonist
03/28/2001EP1086945A1 Composition containing a cyclohexane derivative, compound and use thereof for structuring the composition
03/28/2001EP1086078A1 Neuropeptide y5 receptor antagonists
03/28/2001EP1086065A4 Combinatorial synthesis of multibinding libraries
03/28/2001EP1086065A1 Combinatorial synthesis of multibinding libraries
03/28/2001EP1085893A1 Phosphodiesterase-v modulator drugs and their uses
03/28/2001EP1085891A1 Multibinding inhibitors of topoisomerase
03/28/2001EP1085861A1 Inhibitors of nitric oxide synthase
03/28/2001EP1085846A2 Multibinding inhibitors of microsomal triglyceride transferase protein
03/28/2001EP1085845A2 Multibinding inhibitors of cyclooxygenase-2
03/28/2001EP0876330B1 Aryl or heteroaryl amides of tetrahydronaphthalene, chroman, thiochroman and 1,2,3,4-tetrahydroquinoline carboxylic acids having retinoid-like biological activity
03/28/2001CN1289319A Diterpene derivatives and anti-inflammatory analgesic agents comprising the same
03/28/2001CN1063754C Process for preparing N-alkyl polyhydroxyalkyl amines in aqueous/hydroxy solvents
03/27/2001US6207716 Non-steroidal ligands for the estrogen receptor
03/27/2001US6207709 N-substituted-2-amino-4-phenyl-4-oxo-butanoic acid compounds having kynurenine-3-hydroxy base inhibitory activity
03/27/2001US6207680 Heteroarylpiperidines and their use as antipsychotics and analgesics
03/27/2001US6207629 Concentrated aqueous betaine-type surfactant compositions and process for their preparation
03/27/2001US6207142 Compositions containing an antifungal and a cationic agent
03/27/2001CA2046373C Process for selective epoxidation of unsaturated (meth)-acrylates, novel functional (meth)acrylates thus obtained, and application to the synthesis of novel polymers
03/22/2001WO2001019809A1 Tryptase inhibitors
03/22/2001WO2001019781A1 Method for producing fatty acid amides
03/22/2001WO2001019780A2 Novel derivatives of dicarboxylic acid having pharmaceutical properties
03/22/2001WO2001019778A1 Novel dicarboxylic acid derivatives with pharmaceutical properties
03/22/2001DE19944418A1 Verfahren zum Herstellen von Fettsäureamiden A process for the manufacture of fatty acid amides
03/22/2001CA2384763A1 Tryptase inhibitors
03/21/2001EP1085011A1 Novel polyamine analogues as therapeutic and diagnostic agents
03/21/2001EP1085009A1 Indan derivatives
03/21/2001EP1085000A1 Process for producing carboxylic acid derivative and condensing agent comprising quaternary ammonium salt
03/21/2001EP1084103A1 New 3-aryl-2-hydroxypropionic acid derivative (i)
03/21/2001EP1084102A1 New 3-aryl propionic acid derivatives and analogs
03/21/2001EP1084101A1 New 3-aryl-2-hydroxypropionic acid derivative iii
03/21/2001EP1084100A1 Difluoroalkencarboxanilides and pesticidal compositions
03/21/2001EP1084098A1 Inhibitors of the anandamide transporter as analgesic agents
03/21/2001EP1083920A1 Novel antibacterial compounds
03/21/2001EP1083919A1 Novel antiviral compounds
03/21/2001EP1083894A1 MULTIBINDING INHIBITORS OF HMG-CoA REDUCTASE
03/21/2001EP0717616B1 Process for conditioning substances
03/21/2001CN1288457A Inhibitors of & alpha; 4 mediated cell adhesion
03/21/2001CN1287999A Method for preparing intermediate of methylsalfonamido phenethylamine derivative
03/21/2001CN1063432C N-substituted Cis-Propenyl-acetamides and process for their preparation
03/20/2001US6204391 Water soluble fullerenes with antiviral activity
03/20/2001US6204222 Substituted cyclohexene-1,2-dicarboxylic acid derivatives and intermediates for their preparation
03/20/2001CA2132841C Aminocyclohexylamides for antiarrhythmic and anaesthetic uses
03/15/2001WO2001018171A2 Novel class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof
03/15/2001WO2001018092A1 Polyalkoxylated superamides optionally functionalised, use as emulsifiers
03/15/2001WO2001017953A1 Non-peptidic cyclophilin binding compounds and their use
03/15/2001WO2001017943A1 Pharmaceutical compositions and methods for use
03/15/2001WO2001017904A1 MIXTURES WITH LiPF¿6?
03/15/2001WO2001017673A1 Stable highly active supported copper based catalysts
03/15/2001WO2000051972A8 1,2,3,4-tetrahydro-1-naphthalenamine compounds useful in therapy
03/15/2001DE19943636A1 Neuartige Dicarbonsäurederivate mit pharmazeutischen Eigenschaften Novel dicarboxylic acid derivatives with pharmaceutical properties
03/15/2001DE19943635A1 Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften Novel Aminodicarbonsäurederivate with pharmaceutical properties
03/15/2001CA2384094A1 Pharmaceutical compositions and methods for use
03/15/2001CA2383999A1 Novel class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof
03/15/2001CA2383086A1 Non-peptidic cyclophilin binding compounds and their use
03/15/2001CA2318004A1 Novel polyamine analogues as therapeutic and diagnostic agents
03/14/2001EP1082328A1 Production of optically active phospholanes
03/14/2001EP1082294A1 Phenylalanine derivatives as integrin inhibitors
03/14/2001EP1082293A2 Formoterol polymorphs
03/14/2001EP1082292A2 Control of pain with endogenous cannabinoids
03/14/2001EP1082127A1 SUCCINAMIDE INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME
03/14/2001EP1082121A1 Hiv integrase inhibitors
03/14/2001EP1082115A1 Heterocyclic cis cyclopropane derivatives as melatonergic agents
03/14/2001CN1287117A Cycloene derivate, its producing process and its therapeutical use
03/13/2001US6201024 Effective p2x7 receptor antagonists for use in the treatment of inflammatory, immune or cardiovascular disorders
03/13/2001US6201023 Methods and compositions to protect crops against plant parasitic nematodes
03/13/2001US6201021 Pentanoic acid derivatives
03/13/2001US6200938 Amphoteric derivatives of aliphatic polyamines with fatty acids, esters or triglycerides for consumer products and industrial applications
03/13/2001CA2167651C Biologically highly active bicyclic aromatic compositions; pharmaceutical and cosmetic compositions containing the same and their use
03/08/2001WO2001016211A1 Amphipathic compound having dendritic structure
03/08/2001WO2001016091A1 Biscyclopropanecarboxylic acid amide compounds and medicinal use thereof
03/08/2001WO1999064047A8 Novel antiviral compounds
03/08/2001WO1999019296A8 Aminobutanoic acid derivatives
03/08/2001DE19942021A1 Gemische mit LiPF¶6¶ Mixtures with LiPF¶6¶
03/08/2001DE19937537A1 Substituierte 2-Dialkylaminoalkylbiphenyl-Derivate 2-substituted derivatives Dialkylaminoalkylbiphenyl
03/07/2001EP1081144A2 Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems
03/07/2001EP1081143A1 Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems
03/07/2001EP1080096A1 Novel furylphosphines and organometallic complexes containing them
03/07/2001EP1080068A1 Modulators of protein tyrosine phosphatases
03/07/2001EP1080067A1 Biodegradable corrosion inhibitors
03/07/2001EP1080066A1 Bioreductive cytotoxic agents
03/07/2001EP1079825A2 Compounds that inhibit the binding of integrins to their receptors
03/07/2001EP0793640B1 Method of synthesizing a 2-substituted nitrogen-containing compound
03/07/2001CN1286687A Method for preparation of citalopram
03/07/2001CN1286680A Poly (dialkylaminoalkyl (meth) acrylamide) -based superabsorbent gels
03/07/2001CN1286251A Method for preparing 5-lipooxygenase inhibitor having changeable heterocycle system
03/07/2001CN1286250A Method for preparing 5-lipooxygenase inhibitor having changeable heterocycle system
03/07/2001CN1286246A N-acylamino-acid ester and N-acylamino-acetal preparing process
03/06/2001US6197998 Adding dropwise to aqueous suspension of tyrosine two equivalents or more of haloacetyl halide and aqueous solution of inorganic base simultaneously to form n-haloacetyltyrosine, reacting with ammonium ion to form n-glycyltyrosine
03/06/2001US6197993 Prostaglandin e2 antagonists or agonists
03/06/2001US6197906 Assymetric agents such as (2-methacryloyloxyethyl)acrylamide, (2-acryloyloxyethyl)methacrylamide, and (n-methyl-n-acryloylamino)ethyl methacrylate
03/06/2001US6197798 Inhibitors of microsomal triglyceride transfer protein
03/06/2001US6197773 N-acyl and N-aroyl aralkyl amides as serotonergic agents